ABBV FY 2014 Earnings Report — AbbVie Inc. Revenue & Financial Results | Market Cap Arena

AbbVie Inc.ABBV

FY 2014 Earnings

Reported February 20, 2015

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2014	Prior Q	FY 2013	QoQ Change	YoY Change
Revenue	$20.0B	—	$18.8B	—	6.2%
Op. Income	$3.4B	—	$5.7B	—	-39.8%
Gross Margin	77.8%	—	75.6%	—	2.2pp
Net Margin	8.9%	—	22.0%	—	-13.1pp
EPS (Diluted)	$1.10	—	$2.56	—	-57.0%
Free Cash Flow	$2.9B	—	$5.8B	—	-49.2%

Revenue Flow

Item	Amount
REVENUE	$20.0B
Cost of Revenue	$4.4B
GROSS PROFIT	$15.5B
R&D Expenses	$3.6B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$7.7B
Other Expenses	$750M
Operating Expenses	$12.1B
Cost & Expenses	$16.5B
OPERATING INCOME	$3.4B
Interest Income	$38M
Interest Expense	$429M
Other Income/Expenses	-$1.0B
INCOME BEFORE TAX	$2.4B
Income Tax Expense	$595M
Net Income from Continuing Ops	$1.8B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.8B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.8B
D&A	$786M
EBIT	$2.8B
EBITDA	$3.6B
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$20.0B
Cost of Revenue	$4.4B
GROSS PROFIT	$15.5B
R&D Expenses	$3.6B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$7.7B
Other Expenses	$750M
Operating Expenses	$12.1B
Cost & Expenses	$16.5B
OPERATING INCOME	$3.4B
Interest Income	$38M
Interest Expense	$429M
Other Income/Expenses	-$1.0B
INCOME BEFORE TAX	$2.4B
Income Tax Expense	$595M
Net Income from Continuing Ops	$1.8B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.8B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.8B
D&A	$786M
EBIT	$2.8B
EBITDA	$3.6B
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$1.8B
Depreciation & Amortization	$786M
Stock-Based Compensation	$241M
Deferred Income Tax	$0
Other Non-Cash Items	$1.5B
Change in Working Capital	-$788M
OPERATING CASH FLOW	$3.5B
Capital Expenditure	-$612M
Acquisitions (Net)	-$622M
Purchases of Investments	-$1.2B
Sales/Maturities of Investments	$1.5B
Other Investing Activities	$308M
NET CASH FROM INVESTING	-$926M
Net Debt Issuance	-$5M
Common Stock Repurchased	-$665M
Common Dividends Paid	-$2.7B
Other Financing Activities	$38M
NET CASH FROM FINANCING	-$3.3B
FREE CASH FLOW	$2.9B
Net Change in Cash	-$1.2B

Balance Sheet

Item	Amount
Cash & Equivalents	$8.3B
Short-Term Investments	$26M
Net Receivables	$3.7B
Inventory	$1.1B
Other Current Assets	$1.1B
TOTAL CURRENT ASSETS	$16.1B
PP&E (Net)	$2.5B
Goodwill	$5.9B
Intangible Assets	$1.5B
Long-Term Investments	$92M
Tax Assets	$0
Other Non-Current Assets	$1.5B
TOTAL NON-CURRENT ASSETS	$11.4B
TOTAL ASSETS	$27.5B
Account Payables	$1.4B
Short-Term Debt	$4.4B
Deferred Revenue	$0
Other Current Liabilities	$0
TOTAL CURRENT LIABILITIES	$11.4B
Long-Term Debt	$10.5B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$1.1B
Other Non-Current Liabilities	$2.8B
TOTAL NON-CURRENT LIABILITIES	$14.4B
TOTAL LIABILITIES	$25.8B
Common Stock	$16M
Additional Paid-In Capital	$4.2B
Retained Earnings	$535M
Treasury Stock	-$972M
Accum. Other Comp. Income	-$2.0B
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$1.7B
Minority Interest	$0
TOTAL EQUITY	$1.7B
TOTAL LIABILITIES & EQUITY	$27.5B
Total Debt	$15.0B
Net Debt	$6.7B